Kendle Recognized by Pfizer Development Operations
Saturday, January 6th, 2007Kendle, a leading, global full-service clinical research organization, today announced it has received the 2006 Pfizer Development Operations Strategic Supplier Excellence Award. Kendle provides functional clinical data management services to Pfizer in support of Pfizer’s global drug development efforts. This is the inaugural year for the award program from Pfizer’s Development Operations. It is intended to recognize the Functional Service Provider (FSP) from the existing pool of FSPs supporting Pfizer’s Development Operations that has demonstrated consistent performance in the areas of quality, service delivery and reliability, innovation and business processes, customer service and responsiveness. The winning FSP also must demonstrate excellence in at least one of these areas.
“It is truly an honor to be recognized in this way by one of our largest customers,” said Candace Kendle, PharmD, Chairman and Chief Executive Officer of Kendle.
Kendle’s Biometrics offerings include clinical data management, biostatistics and scientific programming services. Kendle provides these services for customers worldwide, including many of the world’s largest biopharmaceutical organizations.